Concepedia

Niva Yacov

NY

8

Publications

378

Citations

8

H-Index

2002

Active since

Affiliations

Vascular Biogenics (Israel)(Current)

Sheba Medical Center

Tel Aviv University

Meir Medical Center

Niva Yacov is an author at Vascular Biogenics (Israel) specializing in medicine, pathology, and immunology.

Top concepts

Publications per year

2002–2020

8

Publications

8

Oral tolerance with heat shock protein 65 attenuates mycobacterium tuberculosis-inducedand high-fat-diet-driven atherosclerotic lesions

Dror Harats, Niva Yacov, Boris Gilburd et al. · Journal of the American College of Cardiology · 2002 · 184 citations

, , +7

Rosiglitazone (PPARγ‐agonist) attenuates atherogenesis with no effect on hyperglycaemia in a combined diabetes–atherosclerosis mouse model

Zohar Levi, Aviv Shaish, Niva Yacov et al. · Diabetes Obesity and Metabolism · 2003 · 72 citations

VB-201, an oxidized phospholipid small molecule, inhibits CD14- and Toll-like receptor-2-dependent innate cell activation and constrains atherosclerosis

Itzhak Mendel, Erez Feige, Niva Yacov et al. · Clinical & Experimental Immunology · 2013 · 31 citations · Full text

Drug-Resistant HIV Infection among Drug-Naive Patients in Israel

Zehava Grossman, Margalit Lorber, Shlomo Maayan et al. · Clinical Infectious Diseases · 2004 · 31 citations · Full text

Inhibition of monocyte chemotaxis by VB-201, a small molecule lecinoxoid, hinders atherosclerosis development in ApoE−/− mice

Erez Feige, Niva Yacov, Yaniv Salem et al. · Atherosclerosis · 2013 · 19 citations · Full text

Rows per page

1–5 of 8